Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Market Analysis and Insights: Global Brachytherapy Afterloaders Market
Brachytherapy also known as internal radiotherapy, sealed source radiotherapy, curie therapy or endocurietherapy, is a form of radiotherapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, and skin cancer and can also be used to treat tumors in many other body sites.
Brachytherapy Afterloaders, is kind of machine used in brachytherapy to deliverer radioactive sources into the treatment site, to avoid risk of radiation exposure to clinical staff.
Due to the COVID-19 pandemic, the global Brachytherapy Afterloaders market size is estimated to be worth US$ 98.2 million in 2022 and is forecast to a readjusted size of US$ 108.4 million by 2029 with a CAGR of 1.4% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, HDR Afterloaders accounting for % of the Brachytherapy Afterloaders global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Prostate Cancer segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. Varian, Elekta and Eckert and Zieglar BEBIG are the leaders of the industry, with about 80% market shares. North America is the largest suppliers and consumer of Brachytherapy Afterloaders, with a production market share of 52% and a consumption market share of 55%. The second place is Europe, following North America with the production market share of 34% and a consumption market share of 25%. Asia is another important place enjoying 15% sales market share.
Global Brachytherapy Afterloaders Scope and Market Size
The global Brachytherapy Afterloaders market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Brachytherapy Afterloaders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
HDR Afterloaders
PDR Afterloaders
Segment by Application
Prostate Cancer
Gynecological Cancer
Breast Cancer
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Varian
Elekta
Eckert and Zieglar BEBIG
Brachytherapy also known as internal radiotherapy, sealed source radiotherapy, curie therapy or endocurietherapy, is a form of radiotherapy where a sealed radiation source is placed inside or next to the area requiring treatment. Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, and skin cancer and can also be used to treat tumors in many other body sites.
Brachytherapy Afterloaders, is kind of machine used in brachytherapy to deliverer radioactive sources into the treatment site, to avoid risk of radiation exposure to clinical staff.
Due to the COVID-19 pandemic, the global Brachytherapy Afterloaders market size is estimated to be worth US$ 98.2 million in 2022 and is forecast to a readjusted size of US$ 108.4 million by 2029 with a CAGR of 1.4% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, HDR Afterloaders accounting for % of the Brachytherapy Afterloaders global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Prostate Cancer segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. Varian, Elekta and Eckert and Zieglar BEBIG are the leaders of the industry, with about 80% market shares. North America is the largest suppliers and consumer of Brachytherapy Afterloaders, with a production market share of 52% and a consumption market share of 55%. The second place is Europe, following North America with the production market share of 34% and a consumption market share of 25%. Asia is another important place enjoying 15% sales market share.
Global Brachytherapy Afterloaders Scope and Market Size
The global Brachytherapy Afterloaders market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Brachytherapy Afterloaders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
HDR Afterloaders
PDR Afterloaders
Segment by Application
Prostate Cancer
Gynecological Cancer
Breast Cancer
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Varian
Elekta
Eckert and Zieglar BEBIG
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
